Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

Ambroxol is commonly used as an expectorant in cough syrup, helping thin out mucus so people with respiratory illnesses can ...

A common cough syrup, Ambroxol, has shown potential in slowing the progression of Parkinson's dementia in a recent clinical trial.

A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly ...

Ambroxol – a common cough medicine in Europe – may prevent the progression of dementia in patients with Parkinson's disease, a new trial suggests.

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

Dementia is not an inevitable part of ageing. It is caused by diseases that affect the brain. The most common of these diseases is Alzheimer’s disease. As we get older, our bodies change. These ...

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.

A 12-month study found that Ambroxol helped stabilised psychiatric symptoms and protected against brain damage in genetically ...

Despite the high prevalence of type 2 diabetes worldwide, and the fact that Alzheimer's disease is the most frequent cause of dementia, most of the published literature suggests that type 2 diabetes ...

A cough medicine used for decades in Europe called ambroxol has shown promise for treating dementia in people with ...

Ambroxol, a common cough medicine used in Europe, demonstrated target engagement in people with Parkinson's disease dementia ...